Emergent Biosolutions
Global Life Science Company
Based in MD
AI Overview
With $360K in lobbying spend across 13 quarterly filings, Emergent Biosolutions is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2019 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Emergent Biosolutions disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Disaster Planning, Budget/Appropriations, Homeland Security, Defense, Health Issues and 1 more
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedne
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparednes
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.